Aprea Therapeutics Inc (APRE)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

535 BOYLSTON STREET BOSTON, MA 02116

Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Aprea Therapeutics serves customers in the United States and Sweden.

Data based on most recent fiscal year report
Market Cap815.042 Million Shares Outstanding20.99 Million Avg Volume51.398 Thousand

Are you looking for this stock instead?

View SEC Filings from APRE instead.

View recent insider trading info

Funds Holding APRE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding APRE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KORBEL GREGORY ALAN VP OF BUSINESS DEV'T

  • Officer
0 2020-03-24 1

ATTAR EYAL C. SVP, CHIEF MEDICAL OFFICER

  • Officer
0 2020-03-24 1

ABRAHMSEN LARS B. SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-03-24 1

COIANTE SCOTT M SVP, CHIEF FINANCIAL OFFICER

  • Officer
0 2020-03-24 1

SCHADE CHRISTIAN S PRESIDENT & CEO

  • Officer
  • Director
0 2020-03-24 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

KORBEL GREGORY ALAN - Officer VP OF BUSINESS DEV'T

2020-03-24 A 12,800 a 12,800 0.00 direct

ABRAHMSEN LARS B. - Officer SVP, CHIEF SCIENTIFIC OFFICER

2020-03-24 A 31,600 a 31,600 0.00 direct

SCHADE CHRISTIAN S - Director - Officer PRESIDENT & CEO

2020-03-24 A 127,000 a 127,000 0.00 direct

ATTAR EYAL C. - Officer SVP, CHIEF MEDICAL OFFICER

2020-03-24 A 55,000 a 55,000 0.00 direct

COIANTE SCOTT M - Officer SVP, CHIEF FINANCIAL OFFICER

2020-03-24 A 55,000 a 55,000 0.00 direct

Elevate your investments